CHCl3): þ 8.8 (589), þ 9.0 (578), þ 9.8 (546), þ 12.8 (435),
1
þ 11.4ꢀ (365 nm). H-NMR (CDCl3 , ppm): 0.82 (d, J ¼ 6.32
Yield: 1.9 g (53%). M.p.: 76–77 ꢀC. [a]20 (c ¼ 0.5 in CHCl3):
Hz, 3H), 1.41 (s, 3H) 1.78 (m, 1H), 1.94 (m, 1H), 2.53 (m, 2H),
3.22 (br s, 1H), 3.52 (q, J ¼ 6.32 Hz, 1H), 7.11–7.53 (m,
15H).13C-NMR (CDCl3 , ppm): 14.18, 31.31 (CH3), 42.23,
44.02 (CH2), 59.22 (CH), 75.34, 79.73 (C), 124.96–128.58
(CH), 144.53, 145.53, 148.02 (C). IR (KBr, cm 1): 3500, 3310
(OH), 3260 (NH), 3070, 3040, 3010, 2950, 2910, 2830 (CH),
1492 (C¼C), 1445, 1370 (CH). MS (DCI-NH3): m=z 376
(MHþ ). Anal. calc. for C25H29NO2 : C 79.96, H 7.78, N 3.73;
found C 79.63, H 7.79, N 3.78%.
16.2 (589), 16.7 (578), 19.8 (546), 38.1 (435), 70.8ꢀ
1
(365 nm). H-NMR (CDCl3 , ppm): 0.98 (d, J ¼ 6.32 Hz, 3H),
1.74 (m, 2H), 2.57 (m, 1H), 2.83 (m, 1H), 3.69 (q, J ¼ 6.32 Hz,
1H), 3.87 (br s, 1H), 4.66 (m, 1H), 7.13–7.56 (m, 15H). 13C-
NMR (CDCl3 , ppm): 14.50 (CH3), 38.58, 44.96 (CH2), 59.02
(CH), 73.85, 79.46 (C), 125.63–128.40, 144.54 (CH), 144.82,
146.02 (C). IR (KBr, cm 1): 3414 (OH), 3060, 3020, 2960,
2935, 2810 (CH), 1490 (C¼C), 1450, 1380 (CH). MS (DCI-
NH3): m=z 362 (MHþ ). Anal. calc. for C24H27NO2 : C 79.74,
H 7.53, N 3.87; found C 79.63, H 7.24, N 3.81%.
(1R,2S)-N-(3-Oxobutyl)norephedrine. To
a
solution of
(5S,9S)-Perhydro-5,9-dimethyl-4,4,9-triphenyl-2-(p-vinyl-
phenyl)-1,3,6,2-dioxazaboronine 1. A solution of 6 (5.00 g, 13.3
mmol) and 10 (1.73 g, 4.4 mmol) in benzene (200 ml) was
heated in a round-bottomed flask fitted with a Dean–Stark
trap and a condenser. The solution was refluxed for 4 h and
then cooled to room temperature. The solvent was
evaporated and the residue was purified by column
norephedrine (9.6 g, 63 mmol) in CHCl3 (100 ml) cooled to
0 ꢀC was added dropwise a solution of freshly distilled
methyl vinyl ketone (4.45 g, 63 mmol) in CHCl3 (50 ml). The
solution was stirred overnight and allowed to reach room
temperature. The solvent was evaporated and the resulting
solid was used without further purification. The yield is
practically quantitative. M.p. 72 ꢀC. [a]20
(c ¼ 0.5 in
D
3.3ꢀ. 1H-NMR (CDCl3 , ppm): 0.81 (d, J ¼ 6.53
chromatography (eluent: n-hexane–ethyl acetate
2 : 1;
CHCl3):
Rf ¼ 0.55). The product (4.41 g, 68%) was obtained as a
Hz, 3H), 2.15 (s, 3H), 2.63 (t, J ¼ 6.21 Hz, 2H), 2.88 (m,
2H), 2.97 (dq, J ¼ 6.53 Hz and 3.78 Hz, 1H), 4.74 (d,
J ¼ 3.78 Hz, 1H), 7.30 (m, 5H).13C-NMR (CDCl3 , ppm):
14.50, 30.20 (CH3), 41.52, 43.87 (CH2), 58.48, 73.05, 126.03,
126.99, 128.05 (CH), 141.46, 208.34 (C). IR (KBr, cm 1):
3280 (NH), 3110 (OH), 3060, 3040, 3010, 2970, 2890 (CH),
1705 (C¼O), 1485 (C¼C), 1425, 1365 (CH). MS (DCI-NH3):
m=z 222 (MHþ ). Anal. calc. for C13H19NO2 : C 70.66, H
8.65, N 6.33; found C 70.82, H 8.85, N 6.11%.
1
colorless foam. [a]20 (c ¼ 0.5 in CHCl3): 112.2ꢀ. H-NMR
D
(CDCl3 , ppm): 1.04 (d, J ¼ 6.72 Hz, 3H), 1.23 (s, 3H), 1.93
(m, 2H), 3.35 (m, 1H), 3.98 (m, 1H), 4.33 (dq, J ¼ 6.72 Hz
and 10.22 Hz, 1H), 5.21 (dd, J ¼ 10.87 Hz and 1.04 Hz, 1H),
5.78 (dd, J ¼ 17.62 Hz and 1.04 Hz, 1H), 6.77 (dd, J ¼ 10.87
Hz and 17.62 Hz, 1H), 7.08–7.52 (m, 17H), 7.60 (d, J ¼ 7.93
Hz, 2H).13C-NMR (CDCl3 , ppm): 16.44, 30.33 (CH3), 34.43,
42.86 (CH2), 62.95 (CH), 73.33, 85.07 (C), 112.44 (CH2),
124.91–128.09, 131.32 (CH), 135.51 (C), 137.40 (CH), 144.39,
147.01, 150.09 (C). 11B-NMR (CDCl3 , ppm): 6.15. IR (KBr,
cm 1): 3040, 3010, 2950 (CH), 1625 (vinyl-C¼C), 1595, 1490
(C¼C), 1440, 1390, 1365 (CH). MS (DCI-NH3): m=z 505
(1R,2S)-2-[(3S)-3-Hydroxy-3-phenylbutyl]amino-1-phenyl-
propanol 8. A solution of phenylmagnesium bromide was
prepared by standard methods from magnesium turnings
(5.36 g, 0.22 mol), bromobenzene (31.49 g, 0.20 mol) and dry
(Mþ þ NH3), 488 (MHþ ), 384 (MHþ
vinylphenyl). Anal.
calc. for C33H34BNO2 : C 81.31, H 7.03, N 2.87; found C
80.93, H 6.95, N 2.78%.
diethyl ether (200 ml).
A
solution of 1(R,2S)-N-(3-
oxobutyl)norephedrine (14.8 g, 0.067 mol) in diethyl ether
(200 ml) was added dropwise at room temperature. The
reaction mixture was stirred for 3 h and hydrolysed with
saturated NH4Cl and water. After standard workup the crude
product was crystallised twice from 1 : 1 CHCl3–n-hexane.
Yield: 3.84 g (19%). M.p.: 140 ꢀC. [a]20 (c ¼ 0.5 in CHCl3):
225.7ꢀ (365 nm). 1H-NMR (CDCl3 , ppm): 0.85 (d,
J ¼ 6.53 Hz, 3H), 1.48 (s, 3H), 1.93 (m, 2H), 2.34 (m, 1H),
2.66 (dq, J ¼ 6.53 Hz and 3.84 Hz, 1H), 2.91 (m, 1H), 4.66
(d, J ¼ 3.84 Hz, 1H), 7.17–7.38 (m, 10H).13C-NMR CDCl3 ,
ppm): 13.66, 31.52 (CH3), 41.50, 43.90 (CH2), 59.00, 75.20
(CH), 75.68 (C), 124.91–128.21 (CH), 142.03, 148.36 (C). IR
(KBr, cm 1): 3310 (OH), 3250 (NH), 3040, 2960, 2900, 2840
(CH), 1490, 1470 (C¼C), 1440, 1365 (CH). MS (DCI-NH3):
m=z 300 (MHþ ). Anal. calc. for C19H25NO2 : C 76.22, H
8.42, N 4.68; found C 76.42, H 8.45, N 4.95%.
General procedure for the synthesis of the template monomers
2–4. A solution of one of the dialcoholamines 7–9 (10–20
mmol) and 10 (0.33 equiv.) in benzene (200 ml) was heated
in a round-bottomed flask fitted with a Dean–Stark trap and
a condenser. The solution was refluxed for 1 h. During this
time, the Dean–Stark trap was periodically emptied so that
about 150 ml of the solvent were distilled off. The product
(about 80% yield) separated from the solution as a white
amorphous solid upon cooling.
66.9 (589),
69.7 (578),
79.2 (546),
138.5 (435),
(5S,9R)-Perhydro-5,9-dimethyl-4,4,9-triphenyl-2-(p-vinyl-
phenyl)-1,3,6,2-dioxazaboronine 2. M.p.: 205 ꢀC. [a]20D (c ¼ 0.5
in CHCl3): 38.0ꢀ. 1H-NMR (CDCl3 , ppm): 0.95 (s, 3H) 0.97
(d, J ¼ 6.92 Hz, 3H), 2.07 (m, 2H), 3.08 (m, 1H), 3.27 (m, 1H),
3.53 (m, 1H), 4.33 (dq, J ¼ 6.92 Hz and 3.70 Hz, 1H), 5.11 (dd,
J ¼ 10.86 Hz and 1.16 Hz, 1H), 5.65 (dd, J ¼ 17.66 Hz and 1.16
Hz, 1H), 6.53 (dd, J ¼ 10.86 Hz and 17.66 Hz, 1H), 7.02–7.53
(m, 17H), 7.82 (d, J ¼ 7.12 Hz, 2H).13C-NMR (CDCl3 , ppm):
18.60, 32.77 (CH3), 34.23, 44.61 (CH2), 63.75 (CH), 72.25,
85.51 (C), 111.95 (CH2), 124.90–128.31, 131.96 (CH), 134.91
(C), 137.50 (CH), 145.53, 147.27, 149.72 (C). 11B-NMR
(CDCl3 , ppm): 6.63. IR (KBr, cm–1): 3280 (NH), 3050, 3020,
2970 (CH), 1625 (vinyl-C¼C), 1595, 1490 (C¼C), 1440,
1390, 1365 (CH). MS (DCI-NH3): m=z 505 (Mþ þ NH3), 488
(MHþ ), 384 (MHþ vinylphenyl). Anal. calc. for
C33H34BNO2 : C 81.31, H 7.03, N 2.87; found C 80.98, H
7.14, N 2.78%.
(2S)-2-[(3S)-3-Hydroxy-3-phenylpropyl]amino-1,1-diphenyl-
propanol 9. A solution of 5 (3.6 g, 10 mmol) in 100 ml dry THF
was cooled to
60 ꢀC under an inert atmosphere. A 1 M
solution of borane in THF (20 ml) was added with stirring
during 30 min with a syringe pump. After the addition, the
solution was stirred overnight and allowed to slowly reach
room temperature. The solution was hydrolysed by cautious
dropwise addition of methanol and evaporated to dryness.
The residue was taken up in diethyl ether (100 ml) and washed
two times with 0.2 M NaOH (50 ml) and two times with water
(50 ml). The solution was dried over Na2SO4 and evapor-
ated to dryness. The residue was purified by column
chromatography (eluent: n-hexane–ethyl acetate–triethylamine
20 : 10 : 1; Rf ¼ 0.23). The fractions were evaporated to dryness
and the oily residue crystallised upon standing at room
(4R,5S,9S)-Perhydro-5,9-dimethyl-4,9-diphenyl-2-(p-vinyl-
phenyl)-1,3,6,2-dioxazaboronine 3. M.p.: 202 ꢀC. [a]20D (c ¼ 0.5
in CHCl3): 69.1ꢀ. 1H-NMR (CDCl3 , ppm): 0.76 (d, J ¼ 6.92
New J. Chem., 2001, 25, 1537–1542
1541